Scholars Central

Conference abstract

Pharmacutical scale and green process for the synthesis of anticancer drug Pomalidomide

Authors: Reza Hosseinpour

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Pomalidomide (PML), chemically (RS)-4-amino-2-(2,6-dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione, is a small molecule analog of thalidomide developed by Celgene Corporation for the treatment of hematological and connective tissue diseases by oral administration. It is a potent second-generation oral immunomodulatory agent with antineoplastic activity, showing significant activity in multiple myeloma patients with disease refractory to lenalidomide and bortezomib. We develop a new route for the preparation of pomalidomide on the pharmaceutical scale and polymorphic form based on Celgene Corporation. The synthetic procedure starts from 4-nitroisobenzofuran-1,3-dione and 3-aminopiperidine-2,6-dione hydrochloride via a 2 step reaction resulting in a total yield of 95% with a high HPLC purity of 99.98%. PDF HTML

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical & Experimental Pharmacology
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Reza Hosseinpour”